The above chart presents the market trend analysis for r.h.pharma from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 20 transactions, with a transaction quantity of 1544400 and a transaction weight of 0.
YearTransactionsQuantityWeight
20228182734.030
20232015444000
Bill of lading data
<
1/15
>
Trade date
2023/03/28
B/L No.
——
Suppliers
r.h.pharma
Buyers
tms middle east general trading llc
3warwick
pakistanbuyer,they trade on 2021-08-25
20.29%
>
Products
Total 71
ProductsTransactionsPerDetail
surgical instrument 10364.38%>
rust 4628.75%>
surgical disposable 3220%>
jelly 1811.25%>
hea 127.5%>
+View All
Hscode rank
Total 29
HSCode NameTransactionsPerDetail
HS 901890999458.75%>
HS 90183990127.5%>
HS 73239990127.5%>
HS 9018391085%>
HS 9018393074.38%>
+View All
Trading Area
Total 5
AreaTransactionsPerDetail
kyrgyzstan30745.08%>
madagascar659.54%>
kenya416.02%>
senegal202.94%>
england20.29%>
Port statistics
Total 3
Port NameTransactionsPerDetail
nhava sheva sea innsa113619.97%>
nhavasheva innsa111416.74%>
sahar air cargo acc inbom4527.64%>
r.h.pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as surgical instrument,rust,surgical disposable.
According to the 52wmb.com global trade database, as of 2023-03-28, the company has completed 681 international trades,
with its main trading regions covering kyrgyzstan,madagascar,kenya etc.
The core products include HS90189099,HS90183990,HS73239990 etc,
often transported via nhava sheva sea innsa1,port nhavasheva innsa1, port sahar air cargo acc inbom4 etc,
and its main trading partners are meditek,tms middle east general trading llc,warwick.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on r.h.pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.